Co-Authors
This is a "connection" page, showing publications co-authored by Peter Galle and Martin Sprinzl.
Connection Strength
0.916
-
No Evidence for Classic Thrombotic Microangiopathy in COVID-19. J Clin Med. 2021 Feb 09; 10(4).
Score: 0.232
-
Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection. J Investig Med. 2020 08; 68(6):1199-1202.
Score: 0.223
-
Patterns of liver injury in COVID-19 - a German case series. United European Gastroenterol J. 2020 08; 8(7):814-819.
Score: 0.222
-
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2021 09 01; 33(9):1194-1200.
Score: 0.060
-
COVID-19 as a Potential Trigger for Immune Thrombotic Thrombocytopenic Purpura and Reason for an Unusual Treatment: A Case Report. Hamostaseologie. 2021 Jul 29.
Score: 0.060
-
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19. J Thromb Haemost. 2021 09; 19(9):2335-2347.
Score: 0.060
-
Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission. Med Microbiol Immunol. 2021 Jun; 210(2-3):165-171.
Score: 0.059